Galvani Bioelectronics Publishes Splenic Nerve Pilot Study Results
UK-based Galvani Bioelectronics is working to develop a rheumatoid arthritis therapy using splenic nerve stimulation (SpNS). Initial results from the first 11 patients were published in The Lancet this month.